Inframammary Intertrigo: Clinical Presentation, Causes, and Management
Inframammary intertrigo should be managed with a combination of moisture control, topical antifungals or low-potency corticosteroids depending on whether secondary infection is present, and aggressive attention to predisposing factors, with the understanding that keeping the area dry is the single most important intervention.
Clinical Presentation
Inframammary intertrigo presents as erythematous, minimally indurated, nonscaling plaques in the inframammary folds 1. The condition manifests as inflammatory skin changes caused by skin-on-skin friction in the breast folds, with moisture becoming trapped due to poor air circulation 2, 3.
Key diagnostic features include:
- Erythema and maceration in the inframammary crease 2
- Absence of satellite pustules when uncomplicated by secondary candidal infection 1
- Weeping, erosive lesions when secondarily infected with bacteria 4
- Fissures and exudates in more severe cases 4
The condition affects natural and obesity-created body folds, with the inframammary region being a particularly common site 5.
Causes and Predisposing Factors
The primary mechanism is skin-on-skin friction combined with moisture entrapment 2, 3. Critical predisposing factors include:
- Obesity - strongly associated with intertrigo development 3
- Macromastia - large breast size creates deeper, more occlusive folds 6
- Diabetes mellitus - increases susceptibility 7, 5
- Local humidity and heat - exacerbate moisture retention 5, 4
- Poor hygiene practices - hot showers and excessive soap use 8
Secondary infections complicate the clinical picture: Candida species are the most common fungal pathogens, while Staphylococcus aureus and gram-negative bacteria (particularly Pseudomonas aeruginosa) cause bacterial superinfection 9, 10, 4.
Management Algorithm
Step 1: Assess for Secondary Infection
Examine for satellite pustules to distinguish candidal infection from uncomplicated intertrigo 1. The absence of satellite papules or pustules makes secondary candidal infection unlikely 1.
For suspected bacterial infection, look for weeping, erosive, painful lesions 4. Consider bacterial swabs when infection is suspected 8.
Step 2: Initial Treatment Based on Infection Status
For uncomplicated intertrigo (no secondary infection):
- Topical azoles (clotrimazole, miconazole) or nystatin are effective first-line agents 9, 7
- Low-potency topical corticosteroids (hydrocortisone 1% cream) can be used for inflammatory lesions 8
- Apply oil-in-water creams or ointments; avoid alcohol-containing lotions 8
For candidal intertrigo:
- Topical azoles (clotrimazole, miconazole) or nystatin for 7-14 days 9, 7
- Clotrimazole troches or nystatin suspension can be adapted for topical use 9
- Superficial cutaneous candidiasis presenting as intertrigo rarely causes dissemination 10
For bacterial superinfection:
- Topical antibiotics (clindamycin 2%, erythromycin 1%, or metronidazole 0.75%) 8
- Antiseptic preparations containing chlorhexidine or triclosan 11
- Consider systemic antibiotics (doxycycline 100 mg twice daily or minocycline 100 mg twice daily) for moderate to severe cases 8
Step 3: Moisture Control (Critical for All Cases)
Keeping the infected area dry is the most important intervention 9, 7. Specific measures include:
- Avoid hot showers and excessive soap use 8
- Pat skin dry after bathing; avoid rubbing 8
- Apply absorptive powders (cornstarch) or barrier creams to minimize moisture and friction 5
- Use moisture-wicking textiles within skin folds to reduce skin-on-skin friction and wick away moisture 2
- Wear light, nonconstricting, absorbent clothing; avoid synthetic fibers 5
Step 4: Address Predisposing Factors
Educate patients on reducing modifiable risk factors 2:
- Weight reduction in obese patients 3
- Improved glycemic control in diabetic patients 7, 5
- Avoid dehydrating body care practices including hot showers and excessive soap use 8
- Shower after physical exercise and thoroughly dry intertriginous areas 5
Step 5: Consider Surgical Intervention for Refractory Cases
Reduction mammaplasty may be helpful for treating inframammary intertrigo in patients with macromastia 12. This represents weak evidence but addresses the underlying anatomical cause 12. Conservative treatments do not eliminate the cause of macromastia-related intertrigo 6.
Common Pitfalls and Caveats
Do not use high-potency topical corticosteroids in intertriginous areas - these locations have increased absorption risk and potential for skin atrophy 1. Low-potency preparations like hydrocortisone are preferred 8.
Avoid occlusive methods as these significantly increase corticosteroid potency and can worsen moisture retention 1.
Do not overlook associated eczema - this is frequently present (approximately 50% of cases) and requires concurrent treatment with topical corticosteroids 4.
Recognize that inverse psoriasis can mimic intertrigo in intertriginous areas including the breasts 1. The presence of well-demarcated plaques with minimal induration and absence of scaling suggests psoriasis rather than simple intertrigo 1.
Secondary candidiasis must be actively considered when psoriasis or other dermatoses present in body folds where moisture is trapped 1.